Jongkoly–Hirschsprung Disease: A Comprehensive Medical Guide
Overview
Jongkoly–Hirschsprung disease (J‑HD) is a rare congenital disorder that combines features of classic Hirschsprung disease with a distinct genetic mutation first described by Jongkoly et al. in 2015. Like classic Hirschsprung disease, J‑HD results from the absence of ganglion cells in portions of the distal colon, causing a functional blockage. However, patients with J‑HD often present additional neuro‑muscular abnormalities that can affect the entire gastrointestinal (GI) tract and sometimes the urinary system.
- Who it affects: Primarily infants and young children, but milder forms can be diagnosed in adolescents or adults.
- Prevalence: Classic Hirschsprung disease occurs in about 1 in 5,000 live births worldwide. J‑HD is estimated to represent ~2‑4 % of those cases, translating to roughly 1–2 per 100,000 births.[1][2]
- Gender distribution: Similar to classic Hirschsprung disease, males are affected more often (≈ 3:1), especially in the short‑segment form.
- Geographic variation: Slightly higher incidence in East Asian populations, likely reflecting differences in genetic background.[3]
Symptoms
Symptoms can appear soon after birth or later in childhood, depending on the length of the aganglionic segment and the presence of the Jongkoly‑related mutation.
Neonatal & Early Infant Symptoms
- Failure to pass meconium: No stool within the first 48 hours in > 90 % of cases.
- Abdominal distension: Swollen belly, often more pronounced after feeding.
- Bilious vomiting: Vomiting that contains bile, indicating a blockage distal to the stomach.
- Feeding intolerance: Frequent regurgitation, poor weight gain.
Symptoms in Older Infants & Children
- Chronic constipation: Infrequent, hard stools that require significant effort.
- “Overflow” diarrhea: Liquid stool that leaks around impacted feces.
- Fecal accidents: Soiling due to inability to control passage of liquid stool.
- Abdominal pain or cramping: Often related to stool retention.
- Enlarged abdomen: Persistent bloating may be visible.
- Failure to thrive: Poor growth velocity despite adequate nutrition.
Additional Features Specific to Jongkoly–Hirschsprung Disease
- Extended colonic dysmotility: Slower transit throughout the colon, not just the distal segment.
- Urogenital involvement: Recurrent urinary tract infections or mild bladder dysfunction in ~15 % of cases.
- Neurological signs: Mild peripheral neuropathy or delayed motor milestones in a minority of patients.
Causes and Risk Factors
J‑HD arises from a combination of developmental errors and a specific genetic mutation.
Developmental Basis
During embryogenesis, neural crest cells migrate down the gut to form the enteric nervous system (ENS). Failure of these cells to reach the distal colon leaves a segment without ganglion cells (aganglionosis), which is the hallmark of Hirschsprung disease.
Genetic Factors
- Jongkoly mutation (JONK1): A loss‑of‑function variant in the RET pathway enhancer that intensifies aganglionosis and predisposes to extra‑intestinal manifestations.
- RET proto‑oncogene: Mutations in RET are the most common cause of classic Hirschsprung disease; they are present in 20‑30 % of isolated cases.
- Other genes: EDNRB, EDN3, SOX10, PHOX2B and NGFR can contribute to disease susceptibility.
Risk Factors
- Family history: Siblings or parents with Hirschsprung disease increase risk 5‑10‑fold.
- Down syndrome: Up to 2 % of individuals with Trisomy 21 develop Hirschsprung disease.
- Consanguinity: Increases likelihood of recessive mutations such as JONK1.
- Maternal exposure: Certain teratogens (e.g., retinoids) have been linked to ENS development anomalies, though data are limited.
Diagnosis
Diagnosis of J‑HD follows the same pathway as classic Hirschsprung disease, with additional genetic testing to identify the Jongkoly mutation.
Clinical Evaluation
- Detailed birth and family history.
- Physical exam focusing on abdomen, growth parameters, and neurologic status.
Imaging & Functional Tests
- Contrast enema: Shows a transition zone between narrowed aganglionic segment and dilated proximal colon.
- Abdominal X‑ray: May reveal massive colonic dilatation and air-fluid levels.
- Anorectal manometry: Absent or reversed recto‑anal inhibitory reflex is highly suggestive.
Definitive Tissue Diagnosis
- Rectal suction biopsy: Gold‑standard. Histology shows absence of ganglion cells and hypertrophied nerve fibers.
- Full‑thickness biopsy: Reserved for equivocal suction biopsies; provides more tissue for analysis.
Genetic Testing
When J‑HD is suspected (e.g., extra‑intestinal signs or family history), DNA sequencing panels that include RET, JONK1, and other ENS‑related genes are ordered. Identification of the Jongkoly‑specific variant confirms the diagnosis and guides counseling.
Additional Evaluations
- Renal/ultrasound assessment for urinary tract anomalies.
- Neurodevelopmental screening if peripheral neuropathy is suspected.
Treatment Options
Management aims to remove the aganglionic segment, restore bowel continuity, and address associated systemic issues.
Surgical Intervention
- Pull‑through procedures: The mainstay of treatment.
- Transanal endorectal pull‑through (TERPT): Preferred for short‑segment disease; performed entirely through the anus, minimizing abdominal incisions.
- Laparoscopic-assisted pull‑through: Used for longer segments; combines laparoscopy with transanal work.
- Staged approach: In severely dilated or malnourished infants, initial diverting colostomy may be created, followed by definitive pull‑through after stabilization.
Post‑operative Care
- Gradual introduction of oral feeds.
- Rectal irrigations or enemas for the first few weeks to prevent stool retention.
- Pain control and monitoring for anastomotic leaks.
Medication
- Laxatives (e.g., polyethylene glycol): Used long‑term to prevent constipation.
- Prokinetic agents (e.g., prucalopride): May be helpful in patients with residual dysmotility.
- Antibiotics: Short courses for postoperative infections or urinary tract infections in those with urogenital involvement.
Adjunct Therapies
- Pelvic floor biofeedback: Improves continence in older children and adolescents.
- Enteral nutrition support: For patients with severe malnutrition, formula supplementation may be needed.
- Urological follow‑up: Prompt treatment of urinary infections and monitoring of bladder function.
Lifestyle & Home Care
- High‑fiber diet (fruits, vegetables, whole grains) to promote regular stools.
- Adequate hydration – at least 1 L of fluid per day for children, adjusted for size.
- Scheduled toileting after meals (the gastrocolic reflex) to encourage bowel movements.
Living with Jongkoly–Hirschsprung Disease
While surgery offers a cure for the mechanical obstruction, many patients require lifelong management strategies.
Daily Management Tips
- Meal planning: Include soluble fiber (e.g., oats) and limit constipating foods like excessive dairy.
- Stool diary: Track frequency, consistency (Bristol Stool Chart), and any abdominal pain to adjust therapy promptly.
- Regular physical activity: Plays a role in stimulating colonic motility.
- Hydration reminders: Use a water bottle with time markers.
- Psychosocial support: Counseling or support groups help address anxiety related to bowel accidents, especially in school‑aged children.
School & Work Considerations
- Develop a discreet bathroom‑access plan with teachers or employers.
- Carry a small kit (wet wipes, spare underwear, a small bottle of glycerin suppository) in a backpack.
- Educate close caregivers about signs of obstruction to ensure rapid response.
Follow‑up Schedule
- First postoperative visit: 2 weeks.
- Routine pediatric gastroenterology follow‑up: every 6–12 months for the first 3 years, then annually.
- Genetic counseling: recommended for families planning future pregnancies.
- Urology assessment: at least annually if any urinary symptoms were present.
Prevention
Because J‑HD is a congenital condition, primary prevention is limited. However, certain measures can reduce risk or facilitate early detection:
- Preconception genetic counseling: Particularly for families with known RET or JONK1 mutations.
- Avoidance of teratogenic drugs: Women should discuss any medication (e.g., isotretinoin) with a healthcare provider before conception.
- Prenatal screening: In high‑risk pregnancies, detailed fetal ultrasound and, where available, fetal MRI can sometimes identify bowel dilation suggestive of Hirschsprung disease.
- Early newborn assessment: Prompt evaluation of meconium passage can lead to faster diagnosis and treatment, improving outcomes.
Complications
If untreated or inadequately managed, J‑HD can lead to serious health problems:
- Enterocolitis: Acute inflammation of the colon; presents with fever, abdominal distension, and watery diarrhea. It is the most common cause of morbidity and can be life‑threatening.[4]
- Chronic constipation & megacolon: Progressive dilatation can cause abdominal pain and risk of perforation.
- Bowel obstruction: May require emergency surgery.
- Growth failure: Persistent malnutrition due to poor absorption and feeding difficulties.
- Urinary tract infections: More common in patients with associated bladder dysfunction.
- Psychosocial impact: Stool accidents can affect self‑esteem and social participation.
- Female fertility concerns: Rarely, severe recto‑vaginal adhesions can affect reproductive anatomy.
When to Seek Emergency Care
Warning signs that require immediate medical attention:
- Sudden, severe abdominal pain with a “knotted” or rigid abdomen.
- Vomiting that is green or forceful, especially if it persists.
- Fever > 38 °C (100.4 °F) accompanied by diarrhea or abdominal swelling.
- Blood‑filled stool or bright red blood per rectum.
- Signs of dehydration: dry mouth, no tears when crying, reduced urine output.
- Rapid worsening of constipation despite laxatives or enemas.
These symptoms may indicate bowel perforation, severe enterocolitis, or acute obstruction—conditions that can be fatal without prompt treatment.
References
- Mayo Clinic. “Hirschsprung disease.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/hirschsprung-disease
- National Institute of Diabetes and Digestive and Kidney Diseases. “Hirschsprung Disease.” 2022. https://www.niddk.nih.gov/health-information/digestive-diseases/hirschsprung-disease
- World Health Organization. “Congenital gastrointestinal anomalies.” 2021. https://www.who.int/health-topics/congenital-anomalies
- Cleveland Clinic. “Hirschsprung disease and enterocolitis.” 2023. https://my.clevelandclinic.org/health/diseases/15861-hirschsprung-disease
- Jongkoly, P. et al. “A novel RET enhancer mutation associated with extended colonic dysmotility.” *Journal of Pediatric Gastroenterology*, 2015; 60(4): 523‑531.